Search

Search Constraints

You searched for: Author/Creator Carlucci, Philip

Search Results

1. 1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to patients with extrarenal symptoms. (14th December 2022)

2. 183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus. (April 2019)

3. 619 Prospective Evaluation of anti-SSA/Ro Positive Pregnancies to Address Risk Factors for Fetal Cardiac Disease/Adverse Pregnancy Outcomes and Efficacy of Ambulatory Fetal Heart Rate Monitoring (FHRM) and Rapid Treatment of Emergent Block. (14th December 2022)

4. Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis. Issue 4 (8th March 2019)

5. CT-08 Safety and tolerability of omalizumab, a humanized anti-IgE monoclonal antibody in systemic lupus erythematosus (STOP LUPUS). (August 2018)

6. Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome. Issue 12 (21st August 2018)

7. Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis. Issue 5 (3rd February 2023)

8. Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus. Issue 11 (1st August 2022)

9. Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti‐IgE Monoclonal Antibody in Systemic Lupus Erythematosus. Issue 7 (8th May 2019)